RenovoRx, Inc. (RNXT) is a Healthcare stock trading at $1.31 (as of 2026-08-21), with a market capitalization of $59.31M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Valuation — source: SEC EDGAR (first-party)
Price
$1.31
Market Cap
$59.31M
Price / Book
5.26
Price / Sales
40.96
FCF Yield
-35.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)
$1.12M
Net Margin
-994.5%
Revenue Growth (YoY)
2511.6%
EPS Growth (YoY)
-20.0%
FCF Growth (YoY)
20.1%
Financial Health — source: SEC EDGAR
Altman Z-Score
-1.40 (distress)
Valuation vs Sector & Industry
Sector P/E (Healthcare)
21.7
Industry P/E (Pharmaceutical Products)
17.0
Company
Sector
Healthcare
Industry
Pharmaceutical Products
Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)